Skip to main content
Clinical Trials/ITMCTR2000003886
ITMCTR2000003886
Recruiting
Phase 1

Study on the characteristics of immune cell infiltration and its correlation with prognosis in patients with stage III B - IV lung adenocarcinoma by PET-CT based on the theory of 'protecting field' of traditional Chinese Medicine

Dongfang Hospital of Beijing University of Chinese Medicine0 sitesTBD
Conditionsung cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
ung cancer
Sponsor
Dongfang Hospital of Beijing University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Dongfang Hospital of Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with lung adenocarcinoma confirmed by histopathology and / or cytology;
  • 2\. Patients who were classified as stage III B \- IV according to the 7th edition of TNM staging system published by IASLC;
  • 3\. According to the NCCN guidelines for non\-small cell lung cancer (NSCLC), the first\-line treatment was carried out according to the recist1\.1 evaluation standard for solid tumors;
  • 4\. Patients with at least one cold ablation lesion;
  • 5\. EGFR mutation (\-), ALK rearrangement (\-);
  • 6\. The patients who refused chemotherapy and radiotherapy in recent 1 month planned to receive systemic therapy (oral Chinese Medicine) \+ local treatment (target lesion biopsy \+ cold ablation);
  • 7\. ECOG PS \<\= 2
  • 8\. Patients whose expected survival time was more than 3 months;
  • 9\. Patients with TCM syndrome conforming to any of the five syndromes of lung cancer;
  • 10\. Patients who voluntarily participated in the study and signed informed consent.

Exclusion Criteria

  • 1\. Patients with multiple primary tumors;
  • 2\. Patients with other conditions not suitable for biopsy and cold ablation;
  • 3\. Patients with cold ablation lesions who have received other local minimally invasive treatment, such as radiotherapy, radiofrequency, seed implantation, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials